AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
In this recent study, researchers in Rome, Italy conducted a study "To study concentrations of adipokines in patients with systemic lupus erythematosus (SLE) and the relationship among adipokines, the metabolic syndrome (MeS), and cardiovascular disease (C VD) risk factors. We enrolled 50 SLE patients and 26 controls, all women."
"Leptin, resistin, visfatin, and adiponectin were measured by commercial ELISA kits. MeS prevalence was increased among subjects with SLE. Leptin levels were higher in patients with SLE than controls. Among SLE patients, independent determinants of leptin were insulin levels (p
The researchers concluded: "Leptin was increased in SLE patients and could play a role in SLE-related cardiovascular diseases. (First Release Dec 15 2008; J Rheumatol 2009;36:295-7; doi: 10.3899/jrheum.080503)'."
Vadacca and colleagues published their study in the Journal of Rheumatology (Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic ...